Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Neuron | 2017

Dopamine (DA) transmission mediates numerous aspects of behavior. Although DA release is strongly linked to firing of DA neurons, recent developments indicate the importance of presynaptic modulation at striatal dopaminergic terminals. The endocannabinoid (eCB) system regulates DA release and is a canonical gatekeeper of goal-directed behavior. Here we report that extracellular DA increases induced by selective optogenetic activation of cholinergic neurons in the nucleus accumbens (NAc) are inhibited by CB1 agonists and eCBs. This modulation requires CB1 receptors on cortical glutamatergic afferents. Dopamine increases driven by optogenetic activation of prefrontal cortex (PFC) terminals in the NAc are similarly modulated by activation of these CB1 receptors. We further demonstrate that this same population of CB1 receptors modulates optical self-stimulation sustained by activation of PFC afferents in the NAc. These results establish local eCB actions on PFC terminals within the NAc that inhibit mesolimbic DA release and constrain reward-driven behavior.

Pubmed ID: 29216450 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Tyrosine Hydroxylase Antibody, clone LNC1 (antibody)

RRID:AB_2201528

This monoclonal targets Tyrosine Hydroxylase

View all literature mentions

VGluT1 (vesicular glutamate transporte-1) antibody (antibody)

RRID:AB_2571618

This polyclonal targets mouse VGluT1, 531-560 aa (BC054462)

View all literature mentions

CB1 (cannabinoid receptor-1) antibody (antibody)

RRID:AB_2571591

This polyclonal targets mouse CB1, C-terminal 31 aa (NM007726)

View all literature mentions

GluA1 (GluR1, AMPA-type glutamate receptor subunit-1) antibody (antibody)

RRID:AB_2571752

This polyclonal targets mouse GluA1, 841-907 aa (X57497)

View all literature mentions

Anti-Choline Acetyltransferase Antibody (antibody)

RRID:AB_2079751

This polyclonal targets Choline Acetyltransferase

View all literature mentions

B6;129S6-Chattm2(cre)Lowl/J (organism)

RRID:IMSR_JAX:006410

Mus musculus with name B6;129S6-Chattm2(cre)Lowl/J from IMSR.

View all literature mentions

B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (organism)

RRID:IMSR_JAX:007914

Mus musculus with name B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J from IMSR.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

Anti-Tyrosine Hydroxylase Antibody, clone LNC1 (antibody)

RRID:AB_2201528

This monoclonal targets Tyrosine Hydroxylase

View all literature mentions